TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Molecular Details
01. General Information
Name Matrix metalloproteinase-13
UniProt ID MMP13_HUMAN
Gene Name MMP13
Gene ID 4322
Synonyms
MMP13, CLG3, MANDP1, MDST, MMP-13
Sequence
MHPGVLAAFLFLSWTHCRALPLPSGGDEDDLSEEDLQFAERYLRSYYHPTNLAGILKENA
ASSMTERLREMQSFFGLEVTGKLDDNTLDVMKKPRCGVPDVGEYNVFPRTLKWSKMNLTY
RIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDG
PSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALM
FPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPNPKHPKTPDKCDPSLSLDAITSLRGET
MIFKDRFFWRLHPQQVDAELFLTKSFWPELPNRIDAAYEHPSHDLIFIFRGRKFWALNGY
DILEGYPKKISELGLPKEVKKISAAVHFEDTGKTLLFSGNQVWRYDDTNHIMDKDYPRLI
EEDFPGIGDKVDAVYEKNGYIYFFNGPIQFEYSIWSNRIVRVMPANSILWC
Pathway Map MAP LINK
KEGG ID hsa4322
TTD ID T34296
Pfam PF00045; PF00413; PF01471; PF13582; PF13583; PF13688; PF16313
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 214
Pair Name Paeoniflorin, Talatizidine
Phytochemical Paeoniflorin
Drug Talatizidine
Disease Info [ICD-11: FA20] Rheumatoid arthritis Investigative
Regulate Info Up-regulation Matrix metalloproteinase-13 Expression
Result This study identified PAE and TLT as the main BACs of WTD in alleviating the severity of RA, and also developed a novel combination of PAE and TLT as a promising candidate drug for RA therapy.
03. Reference
No. Title Href
1 Exploring and characterizing a novel combination of paeoniflorin and talatizidine for the treatment of rheumatoid arthritis. Pharmacol Res. 2020 Mar;153:104658. doi: 10.1016/j.phrs.2020.104658. Click
It has been 59211 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP